Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models

Journal of Lipid Research

Volumn 38, Issue 3, 1997, Pages 437-446

  Wilson, G M ^a   Roberts, E A ^b   Deeley, R G ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

colchicine; cytochalasin D; cytoskeleton; polyribosomes; posttranscriptional regulation

Indexed keywords

BILE SALT; COLCHICINE; CYTOCHALASIN B; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PHORBOL ESTER;

ACTIN FILAMENT; ARTICLE; CATABOLISM; CELL DIFFERENTIATION; CELL FRACTIONATION; CHOLESTEROL METABOLISM; CYTOSKELETON; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; LIVER CELL CULTURE; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ACTINS; BLOTTING, NORTHERN; CELL FRACTIONATION; CELL SIZE; COCULTURE TECHNIQUES; COLCHICINE; CYTOCHALASIN D; CYTOSKELETON; DACTINOMYCIN; GENE EXPRESSION REGULATION; HUMANS; KINETICS; LIVER; MICROSCOPY, PHASE-CONTRAST; POLYRIBOSOMES; RECEPTORS, LDL; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030941695     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
2. Zannis, V. I., J. L. Breslow, T. R. SanGiacomo, D. P. Aden, and B. B. Knowles. 1981. Characterization of the major lipoproteins secreted by two human hepatoma cell lines. Biochemistty. 20: 7089-7096.
3. Illingworth, D. R., S. Lindsey, and F. C. Hagemenas. 1984. Regulation of low-density lipoprotein receptors in the human hepatoma cell line HepG2. Exp. Cell Res. 155:518-526.
4. Javitt, N. B. 1990. HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 4: 161-168.
5. Kraft, H. G., S. J. Demosky, K. Schumacher, H. B. Brewer, and J. M. Hoeg. 1992. Regulation of LDL receptor, apoB, and apoE protein and mRNA in HepG2 cells. DNA Cell Biol. 11: 291-300.
6. Tam, S-P., L. Brisette, R. Ramharack, and R. G. Deeley. 1991. Differences between the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor in human hepatoma cells and fibroblasts reside primarily at the translational and post-translational levels. J. Biol. Chem. 266: 16764-16773.
7. Knowles, B. B., C. C. Howe, and D. P. Aden. 1980. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 209: 497-499.
8. Roberts, E. A., M. Le tarte, J. Squire, and S. Yang. 1994. Characterization of human hepatocyte lines derived from normal liver tissue. Hepatology. 19: 1390-1399.
9. Cohen, L. H., M. Griffioen, L. Havekes, D. Schouten, V. van Hinsbergh, and H. J. Kempen. 1984. Effects of compactin, mevalonate and low density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line HepG2. Biochem. J. 222: 35-39.
10. Havekes, L. M., E. C. M. de Wit, and H. M. G. Princen. 1987. Cellular free cholesterol in HepG2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity. Biochem. J. 247: 739-746.
11. Kamps, J. A. A. M., and T. J. G. van Berkel. 1992. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line HepG2 by β-migrating very-low-densiry-lipoprotein and non-lipoprotein cholesterol. Eur. J. Biochem. 206: 973-978.
12. Auwerx, J. H., A. Chait, G. Wolfbauer, and S. S. Deeb. 1989. Involvement of second messengers in regulation of the low-density lipoprotein receptor gene. Mol. Cell. Biol. 9: 2298-2302.
13. Auwerx, J. H., A. Chait, and S. S. Deeb. 1989. Regulation of the low density lipoprotein receptor and hydroxymethylglutaryl coenzyme A reductase genes by protein kinase C and a putative negative regulatory protein. Proc. Natl. Acad. Sci. USA. 86: 1133-1137.
14. Kamps, J. A. A. M., and T. J. C. van Berkel. 1993. Regulation of low-density-lipoprotein receptors in the human hepatoma cell line HepG2. Eur. J. Biochem. 213: 989-994.
15. Sambrook J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 10.13, 11.31.
16. Denhardt, D. T. 1966. A membrane-filter technique for the detection of complementary DNA. Biochem. Biophys. Res. Commun. 23: 641-646.
17. Scott, J. F. 1977. Turnover of ribosomal RNA in cells in culture. Exp. Cell Res. 108: 207-219.
18. Weber, M. J. 1972. Ribosomal RNA turnover in contact inhibited cells. Nature New Biol. 235: 58-61.
19. Abelson, H. T., L. F. Johnson, S. Penman, and H. Green. 1974. Changes in RNA in relation to growth of the fibroblast: II. The lifetime of mRNA, rRNA, and tRNA in resting and growing cells. Cell. 1: 161-165.
20. Freund, J. E. 1988. Modern Elementary Statistics. 7th edition. Prentice-Hall, Englewood Cliffs, NJ. 429-436.
21. Northemann, W., E. Schmelzer, and P. C. Heinrich. 1981. The size and distribution of cytochrome c oxidase subunit IV mRNA between free and membrane-bound polyribosomes. Eur. J. Biochem. 119: 203-208.
22. Hesketh, J. E., and I. F. Pryme. 1991, Interaction between mRNA, ribosomes and the cytoskeleton. Biochem. J. 277: 1-10.
23. Cochrane, A. W. 1987. Ph.D. thesis, Queen's University, Kingston, Ontario, Canada. 70-72.
24. MacDougall, J. R., and R. S. Kerbel. 1995. Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape. Exp. Cell Res. 218: 508-515.
25. Sympson, C. J., and T. E. Geoghegan. 1990. Actin gene expression in murine erythroleukemia cells treated with cytochalasin D. Exp. Cell Res. 189: 28-32.
26. Duronio, V., B. E. Huber, and S. Jacobs. 1990. Partial down-regulation of protein kinase C reverses the growth inhibitory effect of phorbol esters on HepG2 cells. J. Cell. Physiol. 145: 381-389.
27. Dicker, P., and E. Rozengurt. 1980. Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism. Nature. 287: 607-612.
28. Collins, M. K. L., and E. Rozengurt. 1982. Binding of phorbol esters to high affinity sites on murine fibroblastic cells elicits a mitogenic response. J. Cell. Physiol. 112: 42-50.
29. Taketani, Y., and T. Oka. 1983. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate, like epidermal growth factor, stimulates cell proliferation and inhibits differentiation of mouse mammary epithelial cells in culture. Proc. Natl. Acad. Sci. USA. 80: 1646-1649.
30. Rovera, G., T. G. O'Brien, and L. Diamond. 1977. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science. 240: 868-870.
31. Huberman, E., and M. F. Callahan. 1979. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc. Natl. Acad. Sci. USA. 76: 1293-1297.
32. Yamasaki, H., E. Fibach, U. Nudel, I. B. Weinstein, R. A. Rifkind, and P.A. Marks. 1977. Tumor promoters inhibit spontaneous and induced differentiation of murine erythrolenkemia cells in culture. Proc. Natl. Acad. Sci. USA. 74: 3451-3455.
33. Diamond, L., T. G. O'Brien, and G. Rovera. 1977. Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters. Nature. 269: 247-248.
34. Rahilly, M. A., and S. Fleming. 1993. Metabolic requirements for phorbol ester-induced cytoskeletal changes in renal epithelium. J. Pathol. 169: 439-443.
35. Rahilly, M. A., and S. Fleming. 1992. A tumour promoter induces alterations in vinculin and actin distribution in human renal epithelium. J. Pathol. 166: 283-288.
36. Gerstenfeld, L.C., M.H. Finer, and H. Boedtker. 1985. Altered β-actin gene expression in phorbol myristate acetate-treated chondrocytes and fibroblasts. Mol. Cell. Biol. 5: 1425-1433.
37. Siebert, P. D., and M. Fukuda. 1985. Induction of cytoskeletal vimentin and actin gene expression by a tumor-promoting phorbol ester in the human leukemic cell line K562. J. Biol. Chem. 260: 3868-3874.
38. Latham, V. M., E. H. Kislauskis, R. H. Singer, and A. F. Ross. 1994. β-Actin mRNA localization is regulated by signal transduction mechanisms. J. Cell Biol. 126: 1211-1219.
39. Hesketh, J. E., G. Campbell, M. Piechaczyk, and J-M. Blanchard. 1994. Targeting of c-myc and β-globin coding sequences to cytoskeletal-bound polysemes by c-myc 3′ untranslated region. Biochem. J. 298: 143-148.
40. Hovland, R., G. Campbell, I. Pryme, and J. Hesketh. 1995. The mRNAs for cyclin A, c-myc and ribosomal proteins L4 and S6 are associated with cytoskeletal-bound polysomes in HepG2 cells. Biochem. J. 310: 193-196.
41. Zambetti, G., L. Wilming, E. G. Fey, S. Penman, J. Stein, and G. Stein. 1990. Differential association of membrane-bound and non-membrane-bound polysomes with the cytoskeleton. Exp. Cell Res. 191: 246-255.
42. Nomura, K., H. Teraoka, H. Arita, and O. Ohara. 1992. Disorganization of microfilaments is accompanied by down-regulation of α-smooth muscle actin isoform mRNA level in cultured vascular smooth muscle cells. J. Biochem. 112: 102-106.
43. Beresford, G. W., and L. Agius. 1994. Cytochalasin D exerts stimulatory and inhibitory effects on insulin-induced glucokinase mRNA expression in hepatocytes. Mol. Cell. Biochem. 139: 177-184.